4.4 Review

Human Cytokine-Induced Memory-Like Natural Killer Cells

期刊

JOURNAL OF INNATE IMMUNITY
卷 7, 期 6, 页码 563-571

出版社

KARGER
DOI: 10.1159/000382019

关键词

Natural killer cells; Innate memory; Immunotherapy; Cytokine; Cytokine receptor; IL-12; IL-15; IL-18

资金

  1. Siteman Cancer Center/Cancer Frontier Fund at Washington University
  2. Gabrielle's Angel Foundation for Cancer Research [R01AI102924]
  3. Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences [UL1 TR000448, TL1 TR000449]

向作者/读者索取更多资源

Natural killer (NK) cells are innate lymphoid cells that are important for host defense against infection and mediate antitumor responses. Recent reports from several laboratories have identified that NK cells can remember a prior activation event and consequently respond more robustly when restimulated, a property termed innate NK cell memory. NK cell memory has now been identified following hapten exposure, viral infection, and combined cytokine preactivation with IL-12, IL-15, and IL-18. Many questions in the field remain regarding the cellular and molecular mechanisms regulating memory NK cells and their responses, as well as their formation and function in mice and humans. Here we review our current understanding of cytokine-induced memory-like (CIML) NK cells that are generated by combined preactivation with IL-12, IL-15, and IL-18. These cells exhibit enhanced NK cell effector functions weeks after the initial cytokine preactivation. Further, we highlight the preclinical rationale and ongoing therapeutic application of CIML NK cells for adoptive innnnunotherapy in patients with hematologic malignancies. (C) 2015 S. Karger AG, Basel

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Hematology

A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia

Todd A. Fehniger, Jeffrey S. Miller, Robert K. Stuart, Sarah Cooley, Amandeep Salhotra, Julie Curtsinger, Peter Westervelt, John F. DiPersio, Timothy M. Hillman, Nova Silver, Michael Szarek, Leonid Gorelik, Mark W. Lowdell, Eric Rowinsky

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)

Letter Immunology

Comment on: Evidence of innate lymphoid cell redundancy in humans

Jordan S. Orange, Emily M. Mace, Anthony R. French, Wayne M. Yokoyama, Todd A. Fehniger, Megan A. Cooper

NATURE IMMUNOLOGY (2018)

Editorial Material Immunology

Mystery Solved: IL-15

Todd A. Fehniger

JOURNAL OF IMMUNOLOGY (2019)

Article Immunology

MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells

Melissa M. Berrien-Elliott, Yaping Sun, Carly Neal, Aaron Ireland, Maria C. Trissal, Ryan P. Sullivan, Julia A. Wagner, Jeffrey W. Leong, Pamela Wong, Annelise Y. Mah-Som, Terrence N. Wong, Timothy Schappe, Catherine R. Keppel, Victor S. Cortez, Efstathios G. Stamatiades, Ming O. Li, Marco Colonna, Daniel C. Link, Anthony R. French, Megan A. Cooper, Wei-Le Wang, Mark P. Boldin, Pavan Reddy, Todd A. Fehniger

IMMUNITY (2019)

Article Cell Biology

Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis

Madison R. Mack, Jonathan R. Brestoff, Melissa M. Berrien-Elliott, Anna M. Trier, Ting-Lin B. Yang, Matthew McCullen, Patrick L. Collins, Haixia Niu, Nancy D. Bodet, Julia A. Wagner, Eugene Park, Amy Z. Xu, Fang Wang, Rebecca Chibnall, M. Laurin Council, Carrie Heffington, Friederike Kreisel, David J. Margolis, David Sheinbein, Paola Lovato, Eric Vivier, Marina Cella, Marco Colonna, Wayne M. Yokoyama, Eugene M. Oltz, Todd A. Fehniger, Brian S. Kim

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Cell Biology

Potently Cytotoxic Natural Killer Cells Initially Emerge from Erythro-Myeloid Progenitors during Mammalian Development

Carissa Dege, Katherine H. Fegan, J. Philip Creamer, Melissa M. Berrien-Elliott, Stephanie A. Luff, Darren Kim, Julia A. Wagner, Paul D. Kingsley, Kathleen E. McGrath, Todd A. Fehniger, James Palis, Christopher M. Sturgeon

DEVELOPMENTAL CELL (2020)

Article Hematology

CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas

Margery Gang, Nancy D. Marin, Pamela Wong, Carly C. Neal, Lynne Marsala, Mark Foster, Timothy Schappe, Wei Meng, Jennifer Tran, Maximilian Schaettler, Marco Davila, Feng Gao, Amanda F. Cashen, Nancy L. Bartlett, Neha Mehta-Shah, Brad S. Kahl, Miriam Y. Kim, Matthew L. Cooper, John F. DiPersio, Melissa M. Berrien-Elliott, Todd A. Fehniger

Article Cell Biology

Stage-Specific Requirement for Eomes in Mature NK Cell Homeostasis and Cytotoxicity

Julia A. Wagner, Pamela Wong, Timothy Schappe, Melissa M. Berrien-Elliott, Celia Cubitt, Natalia Jaeger, Madeline Lee, Cassie R. Keppel, Nancy D. Marin, Jennifer A. Foltz, Lynne Marsala, Carly C. Neal, Ryan P. Sullivan, Stephanie E. Schneider, Molly P. Keppel, Nermina Saucier, Megan A. Cooper, Todd A. Fehniger

CELL REPORTS (2020)

Article Biology

CD56 regulates human NK cell cytotoxicity through Pyk2

Justin T. Gunesch, Amera L. Dixon, Tasneem A. M. Ebrahim, Melissa M. Berrien-Elliott, Swetha Tatineni, Tejas Kumar, Everardo Hegewisch-Solloa, Todd A. Fehniger, Emily M. Mace

Article Hematology

Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient

Aabha Oza, Michael P. Rettig, Phil Powell, Kathryn O'Brien, David B. Clifford, Julie Ritchey, Leah Gehrs, Julia Hollaway, Eugene Major, Todd A. Fehniger, Christopher A. Miller, Patrick Soon-Shiong, Amy Rock, John F. DiPersio

BLOOD ADVANCES (2020)

Article Oncology

Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma

Shama Jaswal, Vanessa Sanders, Priyanka Pullarkat, Stephanie Teja, Amber Salter, Marcus P. Watkins, Norman Atagu, Daniel R. Ludwig, Joyce Mhlanga, Vincent M. Mellnick, Linda R. Peterson, Nancy L. Bartlett, Brad S. Kahl, Todd A. Fehniger, Armin Ghobadi, Amanda F. Cashen, Neha Mehta-Shah, Joseph E. Ippolito

Summary: In many cancers, including lymphoma, males have higher incidence and mortality than females. One mechanism underlying this phenomenon is sex differences in metabolism, both with respect to tumor nutrient consumption and systemic alterations in metabolism, i.e., obesity. This study found that visceral fat and tumor glucose uptake can predict outcomes in DLBCL patients in a sex-specific fashion.

CANCERS (2022)

Review Hematology

Allogeneic natural killer cell therapy

Melissa M. Berrien-Elliott, Miriam T. Jacobs, Todd A. Fehniger

Summary: Interest in adoptive cell therapy for cancer is growing, and natural killer (NK) cells are being explored as an alternative to T cells. NK cells have advantages such as immediate availability, no graft-versus-host disease, and lower toxicity. Basic advances in NK cell biology and engineering have led to promising clinical trials and the development of off-the-shelf cellular therapies for blood cancers.
Article Hematology

Memory-like natural killer cells for cancer immunotherapy

Margery Gang, Pamela Wong, Melissa M. Berrien-Elliott, Todd A. Fehniger

SEMINARS IN HEMATOLOGY (2020)

暂无数据